Sun European to exit NextPharma to CapVest
Sun European Partners has agreed to sell pharmaceutical testing and development business NextPharma to CapVest in a transaction that values the business at around €200m.
Sun
Sun European Partners has agreed to sell pharmaceutical testing and development business NextPharma to CapVest in a transaction that values the business at around €200m.
Sun